Hindman Andrew A. 4
4 · Theravance Biopharma, Inc. · Filed Feb 24, 2020
Insider Transaction Report
Form 4
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2020-02-20$25.90/sh−7,060$182,854→ 106,490 total
4 · Theravance Biopharma, Inc. · Filed Feb 24, 2020
Ordinary Shares